Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma.

Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma.

Adoptive immunotherapy using CTL has provided some clinical benefit to patients with metastatic melanoma. Use of cloned CTL of known specificity might improve clinical effect, but technical difficulties have limited exploration of this possibility. We have used fluorescence-driven cell sorting to cl...

Full description

Bibliographic Details
Main Authors:	Dunbar, P, Chen, J, Chao, D, Rust, N, Teisserenc, H, Ogg, G, Romero, P, Weynants, P, Cerundolo, V
Format:	Journal article
Language:	English
Published:	1999

Similar Items

Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein.
by: Gileadi, U, et al.
Published: (1999)

Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood.
by: Dunbar, P, et al.
Published: (1998)

Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes.
by: Ogg, G, et al.
Published: (2000)

Role of the proteasome and non proteasomal proteases in the generation of CTL epitopes.
by: Cerundolo, V, et al.
Published: (1998)

Immunotherapy of melanoma.
by: Smith, C, et al.
Published: (2001)

Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent.
by: Whelan, J, et al.
Published: (1999)

Immunotherapy Tolerance―Cutting Edge
by: Akio Mori
Published: (2013-01-01)

Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence.
by: Smith, C, et al.
Published: (2005)

Differences in phenotype and function between spontaneously occurring melan-A-, tyrosinase- and influenza matrix peptide-specific CTL in HLA-A*0201 melanoma patients.
by: Maczek, C, et al.
Published: (2005)

A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response.
by: Dunbar, P, et al.
Published: (2000)

Cloning CTL-Specific Genes (and now for something completely differential)
by: R Chris Bleackley
Published: (2014-10-01)

Efficiency of ADOPTIVE immunotherapy for melanoma: a case REPORT
by: E. V. Abakushina, et al.
Published: (2016-11-01)

Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma
by: Marieke J. Krimphove, et al.
Published: (2019-11-01)

Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara.
by: Smith, C, et al.
Published: (2005)

Specific Patterns of Blood ILCs in Metastatic Melanoma Patients and Their Modulations in Response to Immunotherapy
by: Louise Rethacker, et al.
Published: (2021-03-01)

The T cell receptor from an influenza-A specific murine CTL clone.
by: Palmer, MS, et al.
Published: (1989)

Competition between CTL narrows the immune response induced by prime-boost vaccination protocols.
by: Palmowski, M, et al.
Published: (2002)

Adoptive immunotherapy of experimental tumors using cytotoxic lymphocytes to carry and deliver toxins.
by: Zanovello, P, et al.
Published: (1991)

High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo.
by: Ogg, G, et al.
Published: (1998)

Exploiting retrograde transport of Shiga-like toxin 1 for the delivery of exogenous antigens into the MHC class I presentation pathway.
by: Noakes, K, et al.
Published: (1999)

Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL.
by: Chen, J, et al.
Published: (2000)

Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells.
by: Aosai, F, et al.
Published: (1991)

High avidity antigen-specific CTL identified by CD8-independent tetramer staining.
by: Choi, E, et al.
Published: (2003)

Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue.
by: Valmori, D, et al.
Published: (2000)

Kinetics of the HBV-specific CTL response
by: Maini, M, et al.
Published: (1999)

CTL-mediated immunotherapy can suppress SHIV rebound in ART-free macaques
by: Jin Fan, et al.
Published: (2019-05-01)

Science at the edge : Cloning /
by: Morgan, Sally, author
Published: (c200)

The efficiency of antigen recognition by CD8+ CTL clones is determined by the frequency of serial TCR engagement.
by: Hudrisier, D, et al.
Published: (1998)

Modulation of CD103 expression on human colon carcinoma-specific CTL.
by: Ling, K, et al.
Published: (2007)

Generation and enrichment of antigen-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy.
by: Oelke, M, et al.
Published: (2000)

IMMUNOTHERAPY FOR MELANOMA
by: E. A. Borobova, et al.
Published: (2017-09-01)

Asymmetric T-cell division: insights from cutting-edge experimental techniques and implications for immunotherapy
by: Yaroslav Kaminskiy, et al.
Published: (2024-03-01)

An antigen-targeted approach to adoptive transfer therapy of cancer.
by: Valmori, D, et al.
Published: (1999)

Melanoma cell lysosome secretory burst neutralizes the CTL-mediated cytotoxicity at the lytic synapse
by: Roxana Khazen, et al.
Published: (2016-03-01)

Melanoma Immunotherapy: Next-Generation Biomarkers
by: Sabrina A. Hogan, et al.
Published: (2018-05-01)

An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions.
by: Anichini, A, et al.
Published: (1999)

Human CD8+ CTL specific for the mycobacterial major secreted antigen 85A.
by: Smith, S, et al.
Published: (2000)

Cutting edge /
by: Harvey, John, 1938-
Published: (1991)

Enhanced immunogenicity of CTL antigens through mutation of the CD8 binding MHC class I invariant region.
by: Wooldridge, L, et al.
Published: (2007)

Counting CTL
by: François Laroussinie, et al.
Published: (2013-02-01)